Protara Therapeutics to Participate in Upcoming Investor Conferences
Provided By GlobeNewswire
Last update: May 13, 2025
NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced that management will participate in the following investor conferences:
Read more at globenewswire.com
